Navigation Links
PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis
Date:12/21/2010

SOUTH PLAINFIELD, N.J., Dec. 21, 2010 /PRNewswire/ -- PTC Therapeutics, Inc. announced today that it has completed enrollment of a Phase 3 clinical trial of ataluren, an investigational new drug, in patients with nonsense mutation cystic fibrosis (nmCF).

(Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO)

The 48-week study is designed to determine whether ataluren can improve lung function in patients with nmCF.  The trial has enrolled 238 patients at 36 sites in North America, Europe and Israel.  Patients who complete the treatment phase of the Phase 3 trial are eligible to participate in a 48-week, open-label extension study, which has begun enrolling patients.

"The enrollment of this trial represents an important step forward in our efforts to develop disease-modifying treatments that advance the standard of care in CF and improve quality of life for CF patients," stated Michael Konstan, MD, Chairman, Department of Pediatrics at Rainbow Babies and Children's Hospital in Cleveland, Ohio.  Dr. Eitan Kerem, Head, Department of Pediatrics and CF Center, Hadasash University Hospital, Jerusalem, Israel added, "Despite significant advances in the 21 years since the identification of the disease-causing gene, cystic fibrosis remains a debilitating and life-threatening disorder and available therapies focus only on alleviating symptoms. Ataluren couples a patient's genetic diagnosis with a mutation-specific therapeutic approach designed to address the underlying cause of the disease."

Ataluren is a protein restoration therapy designed to enable the formation of full-length, functional cystic fibrosis transmembrane regulator (CFTR) protein in patients with cystic fibrosis due to a nonsense mutation.  CFTR is a critical protein lacking in CF patients.  Nonsense mutations are categorized as Class I mutations that result in little or no production of the CFTR protein.  CF patients with Class I mutations typi
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015 Dynatronics Corporation (the "Company") ... of rehabilitation and physical therapy products, announced today ... raise approximately $4,000,000 in a private placement financing ... its affiliates (together with its affiliates, "Prettybrook"), a ... industry. The financing will provide Dynatronics with additional ...
(Date:5/4/2015)... 4, 2015   Mallinckrodt plc (NYSE: MNK ... May 13, 2015, at the Bank of America Merrill Lynch ... in Las Vegas, Nev. ... Financial Officer, and Cole Lannum , Senior Vice President ... company in a session scheduled to begin at 3 p.m. ...
(Date:5/4/2015)... Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ), ... of proprietary compounded drug therapies, today reported that it ... Wednesday, May 13, 2015.  The company will host a ... on the same day to discuss its financial results ... and webcast will be open to all listeners and ...
Breaking Medicine Technology:Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 3Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 4Mallinckrodt To Present At Bank Of America Merrill Lynch 2015 Health Care Conference 2Imprimis Pharmaceuticals to Host its First Quarter 2015 Financial Report Conference Call and Webcast on May 13, 2015 at 4:30 p.m. EDT 2Imprimis Pharmaceuticals to Host its First Quarter 2015 Financial Report Conference Call and Webcast on May 13, 2015 at 4:30 p.m. EDT 3
... Scientific Corporation (NYSE: BSX ) today announced ... 60th Annual Scientific Session of the American College of ... "Twelve-month results from the PLATINUM Workhorse clinical trial ... Everolimus-Eluting Platinum Chromium (PtCr) Stent as compared to our ...
... DIEGO, March 29, 2011 Awarepoint Corporation announced ... at the First Annual Digital Healthcare Innovation Summit ... Intercontinental New York Barclay in New York. Joining Deady on ... of Dell Healthcare Services and Kaveh Safavi, M.D., vice president ...
Cached Medicine Technology:Boston Scientific Announces Its ACC 2011 Schedule 2Boston Scientific Announces Its ACC 2011 Schedule 3Boston Scientific Announces Its ACC 2011 Schedule 4Boston Scientific Announces Its ACC 2011 Schedule 5Boston Scientific Announces Its ACC 2011 Schedule 6Awarepoint CEO Jay Deady to Serve as Panelist at IBF's Digital Healthcare Innovation Summit 2Awarepoint CEO Jay Deady to Serve as Panelist at IBF's Digital Healthcare Innovation Summit 3
(Date:5/4/2015)... San Diego Fertility Center (SDFC) ... brand new, 13,700 square foot facility scheduled to open ... not only provide fertility treatment and services for the ... and educational events to a number of local and ... door to their current Carmel Valley/Del Mar location and ...
(Date:5/4/2015)... 2015 Elisabeth Rosenthal’s article* on ... and showed the healthcare fraternity as well as ... the downside of balance billing. In definition, balance ... billing a patient for the difference between what ... what the provider chooses to charge. Rosenthal’s article ...
(Date:5/4/2015)... For partners who’d like to become ... Astroglide TTC™ (Trying to Conceive) . Unlike traditional ... levels, Astroglide TTC™ is specially formulated to provide a ... Centers for Disease Control, an average of one ... sustaining a pregnancy, and over 7.4 million women ...
(Date:5/4/2015)... 04, 2015 Peacock Alley knows ... He said, “My mother was the most beautiful woman I ... in lovely, feminine prints and textures to remind ... further than the Eloise Robe to get you there. The ... cap sleeve and tapered waist. It is available in small/medium ...
(Date:5/3/2015)... 2015 Barbara Crone has joined Women’s Excellence ... being of the men, women and families who seek her care, ... care for families in the home. , “When ... wondering if I could complete their care with the delivery of ... my mentor Nurse Midwife, I knew it was time for me ...
Breaking Medicine News(10 mins):Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:Out of Network Balance Billing Without Being Viewed as Fraud 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 3Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 2Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 3Health News:Feminine Classics for Mother's Day Gifts from Peacock Alley 2Health News:Women's Excellence In Midwifery Welcomes Barbara Crone 2
... new role for a new type of T cell in ... nerves to make a neurotransmitter (acetylcholine) that blocks inflammation. The ... it may be possible to treat inflammation and autoimmune diseases ... was published this week in Science. "The discovery ...
... AUGUSTA, Ga. Some of the newest therapies in the ... immune system, Georgia Health Sciences University researchers report. These ... cancer by keeping apart two proteins that prevent key immune ... the cover of the Journal of Immunology suggests that these ...
... - The changing tide of Alzheimer,s diagnosis presents new challenges ... out your Alzheimer,s risk, would you want to know? How ... mean for the many newly diagnosed Americans still in the ... can diagnose Alzheimer,s earlier, no effective interventions have been identified ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, Sept. ... will begin earlier this year, so seniors need to ... they want in 2012, U.S. health officials said Thursday. ... the same for the 99.7 percent of Medicare recipients who ...
... a protein linked to cell division and migration and tied ... at high levels in breast cancer specimens and cell lines. ... active in breast cancer cells than in normal breast cells. ... these findings and others in a paper now online in ...
... HealthDay Reporter , THURSDAY, Sept. 15 (HealthDay News) ... tuberculosis, health officials say the disease is less of a ... But, they add, the ease of travel that,s a hallmark ... beyond risk. "Drug-resistant TB exists all over the world," ...
Cached Medicine News:Health News:T cells making brain chemicals may lead to better treatments for inflammation, autoimmune diseases 2Health News:Newest cancer therapies multi-task to eliminate tumors 2Health News:Safeguards needed to prevent discrimination of early Alzheimer's patients in the workplace 2Health News:Enrollment Period for Medicare Starts Early This Year 2Health News:Study finds protein critical to breast cancer cell proliferation, migration 2Health News:Officials Tackle Multidrug-Resistant TB in Europe 2Health News:Officials Tackle Multidrug-Resistant TB in Europe 3
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
... is ideal for repeated pipetting ... volume FInnpipettes offer the same ... Finnpipette Digital pipettes: New, ... Soft-touch tip ejection, Safety label, ...
Inquire...
... A fixed pipette is ... a single volume. Fixed volume ... and advantages as other Finnpipette ... design, Super blow-out (1-40ul), Soft-touch ...
Medicine Products: